SIE, SIES, GITMO evidence-based guidelines on novel agents (thalidomide, bortezomib, and lenalidomide) in the treatment of multiple myeloma
Ann. hematol; 91 (6), 2012
In this project, we produced drug-specific recommendations targeting the use of new agents for multiple myeloma (MM). We used the GRADE (Grades of Recommendation, Assessment, Development, and Evaluation) system which separates the judgments on quality of evidence from the judgment about strength of recom...
Protocoles de polychimiothérapie antinéoplasique, Protocoles de polychimiothérapie antinéoplasique/administration et posologie, Acides boroniques/usage thérapeutique, Bortézomib/usage thérapeutique, Hématologie/législation et jurisprudence, Hématologie/méthodes, Lénalidomide/usage thérapeutique, Myélome multiple/anatomopathologie, Grading des tumeurs, Pyrazines/administration et posologie, Sociétés médicales/législation et jurisprudence, Thalidomide/usage thérapeutique